RxDoctor Payments Data

Colin Turney, MD

Family Medicine · West Chester, PANPI 1598008856

Payments from drug & device makers

$7,599in general payments, 2019–2025

Across 442 payments — averaging $17.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Novo Nordisk$1K
  • Pfizer$921
  • AstraZeneca$599
  • GSK$452
  • Abbott$274
  • plus $3K from 35 others

What the payments were for

  • Food & beverage$7,599100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$7,599 in reported general payments places this provider in the 90th percentile of 4,967 family medicine providers in Pennsylvania.

See all family medicine providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$48,327
Medicare patients
301
Services billed
650

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin47$62,033
JanuviaSitagliptin Phosphate51$60,271
TrulicityDulaglutide28$35,048
FarxigaDapagliflozin Propanediol25$26,603
EliquisApixaban23$20,423
MyrbetriqMirabegron37$20,319
XareltoRivaroxaban16$17,179
Trelegy ElliptaFluticasone/Umeclidin/Vilanter13$16,455
LinzessLinaclotide20$10,748
Atorvastatin Calcium618$7,813
Rosuvastatin Calcium290$4,959
Omeprazole248$3,511
Metoprolol Succinate194$3,046
Levothyroxine Sodium271$2,906
Losartan Potassium204$2,868

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$197$62,03347 claims
MerckJanuvia$31$60,27151 claims
Lilly USA, LLCTrulicity, Olanzapine$181$35,98863 claims
AstraZenecaFarxiga$599$26,60325 claims
PfizerEliquis$921$20,42323 claims
Astellas Pharma US IncMyrbetriq$142$20,31937 claims
Johnson & JohnsonXarelto$52$17,17916 claims
GSKTrelegy Ellipta$452$16,45513 claims
AbbVieLinzess$1,301$10,74820 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,967 family medicine providers in Pennsylvania.

Other family medicine in West Chester

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →